feeling hot on semaglutide Can Your GLP-1 Medication Make You More Prone to Heat Illness? I accidentally left my semaglutide

The authors of the study concluded that the GLP-1 receptor agonist lixisenatide had a three-point beneficial effect, when compared with placebo, in the change over a 12-month period from a baseline value of approximately 15 points on a 132-point scale measuring motor disability. The active arm improved 0.04 points in the lixisenatide group and worsened 3.04 points in the placebo group

3 Beyond weight loss, the highest dose delivered meaningful reductions in cardiovascular risk factors: triglycerides fell by an average of 37.0%, non-HDL cholesterol by 16.5%, systolic blood pressure by 9.3 mmHg, waist circumference by 7.5 inches and high-sensitivity C-reactive protein by 51.2%

In addition to residual cardiovascular risk despite aggressive LDL reduction, high costs limiting accessibility, and unresolved long-term safety concerns, past failures of HDL-directed therapies such as CETP inhibitors underscore the complexity of lipid biology